Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2021-03-24 4:30 pm Purchase |
2021-03-18 | 13G | PhaseBio Pharmaceuticals, Inc. PHASQ |
RA Capital Management, L.P. | 2,850,000 6.000% |
2,850,000![]() (New Position) |
Filing History |
2021-03-23 4:32 pm Purchase |
2009-02-28 | 13D | Solid Biosciences Inc. SLDB |
RA Capital Management, L.P. | 824,525 11.600% |
159,420![]() (+23.97%) |
Filing History |
2021-03-15 4:38 pm Purchase |
2021-03-10 | 13G | Viridian Therapeutics, Inc. VRDN |
RA Capital Management, L.P. | 388,385 6.300% |
388,385![]() (New Position) |
Filing History |
2021-03-09 4:30 pm Purchase |
2021-03-02 | 13G | ARYA Sciences Acquisition Corp IV ARYD |
RA Capital Management, L.P. | 1,000,000 6.700% |
1,000,000![]() (New Position) |
Filing History |
2021-03-02 4:32 pm Purchase |
2009-02-28 | 13D | Satsuma Pharmaceuticals, Inc. STSA |
RA Capital Management, L.P. | 5,914,252 18.800% |
1,232,394![]() (+26.32%) |
Filing History |
2021-02-19 4:30 pm Purchase |
2021-02-09 | 13D | Vor Biopharma Inc. VOR |
RA Capital Management, L.P. | 11,120,973 30.000% |
11,120,973![]() (New Position) |
Filing History |
2021-02-16 4:39 pm Sale |
2020-12-31 | 13G | Relmada Therapeutics, Inc. RLMD |
RA Capital Management, L.P. | 0 0.000% |
-761,666![]() (Position Closed) |
Filing History |
2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Orchard Therapeutics plc ORTX |
RA Capital Management, L.P. | 1,231,521 12.600% |
195,056![]() (+18.82%) |
Filing History |
2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Novavax, Inc. NVAX |
RA Capital Management, L.P. | 3,788,564 6.000% |
3,788,564![]() (New Position) |
Filing History |
2021-02-16 4:39 pm Sale |
2020-12-31 | 13G | PREVAIL THERAPEUTICS INC PRVL |
RA Capital Management, L.P. | 0 0.000% |
-3,363,605![]() (Position Closed) |
Filing History |
2021-02-16 4:39 pm Sale |
2020-12-31 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
RA Capital Management, L.P. | 4,179,067 9.500% |
-1,243,245![]() (-22.93%) |
Filing History |
2021-02-16 4:39 pm Sale |
2020-12-31 | 13G | Verastem, Inc. VSTM |
RA Capital Management, L.P. | 0 0.000% |
-760,771![]() (Position Closed) |
Filing History |
2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Travere Therapeutics, Inc. TVTX |
RA Capital Management, L.P. | 4,557,867 8.900% |
4,557,867![]() (New Position) |
Filing History |
2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR |
RA Capital Management, L.P. | 5,368,451 6.500% |
5,368,451![]() (New Position) |
Filing History |
2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Curis, Inc. CRIS |
RA Capital Management, L.P. | 385,390 8.500% |
385,390![]() (New Position) |
Filing History |
2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
RA Capital Management, L.P. | 1,823,520 5.900% |
1,823,520![]() (New Position) |
Filing History |
2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | X4 Pharmaceuticals, Inc. XFOR |
RA Capital Management, L.P. | 1,748,021 9.900% |
99,536![]() (+6.04%) |
Filing History |
2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Ascendis Pharma A/S ASND |
RA Capital Management, L.P. | 5,865,338 10.900% |
46,476![]() (+0.80%) |
Filing History |
2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | BCTG Acquisition Corp. BCTG |
RA Capital Management, L.P. | 1,250,000 5.800% |
1,250,000![]() (New Position) |
Filing History |
2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
RA Capital Management, L.P. | 2,805,045 6.200% |
2,805,045![]() (New Position) |
Filing History |